Delving into the Latest Updates on Recombinant adenovirus-hepatocyte growth factor(Academy of Military Medical Sciences) with Synapse

Overview

Basic Info

Drug Type

Growth factors

Synonyms-

Target-

Mechanism-

Therapeutic Areas

Cardiovascular Diseases

Active Indication

Myocardial Ischemia

Inactive Indication-

Originator Organization

Academy of Military Medical Sciences

Active Organization

Beijing Haitai United Pharmaceutical Technology Development Co., Ltd.Chinese PLA Academy of Military Medical Sciences

Inactive Organization

Academy of Military Medical Sciences

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

(1) To preliminarily evaluate the efficacy and safety of intramyocardial injection of recombinant adenovirus-hepatocyte growth factor injection (Ad-HGF) in the treatment of ischemic heart disease during coronary artery bypass grafting; (2) To provide the basis for Phase IIb clinical research of Ad-HGF injection.

Start Date17 Dec 2014

Sponsor / Collaborator

Beijing Haitai United Pharmaceutical Technology Development Co., Ltd.

[+1]

ChiCTR-TRC-14004898 / RecruitingPhase 4IIT

Recombinant adenovirus-hepatocyte growth factor in the treatment of ischemic heart disease

Start Date10 Jul 2014

Sponsor / Collaborator

Chinese People's Liberation Army General Hospital

NCT01925352 / Unknown statusPhase 1/2IIT

Phase 2 Study of Adenovirus Hepatocyte Growth Factor for Treatment of Ischemic Heart Disease

To explore the safety and efficiency of adenovirus-hepatocyte growth factor(Ad-HGF) treatment in ischemic heart disease.

Start Date01 Nov 2012

Sponsor / Collaborator

Third Affiliated Hospital of Nanjing Medical University

[+1]

100 Clinical Results associated with Recombinant adenovirus-hepatocyte growth factor(Academy of Military Medical Sciences)

Login to view more data

100 Translational Medicine associated with Recombinant adenovirus-hepatocyte growth factor(Academy of Military Medical Sciences)

Login to view more data

100 Patents (Medical) associated with Recombinant adenovirus-hepatocyte growth factor(Academy of Military Medical Sciences)

Login to view more data

100 Deals associated with Recombinant adenovirus-hepatocyte growth factor(Academy of Military Medical Sciences)

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Myocardial Ischemia	Phase 2	CN	Beijing Haitai United Pharmaceutical Technology Development Co., Ltd.	01 Nov 2010
Myocardial Ischemia	Phase 2	CN	Chinese PLA Academy of Military Medical Sciences	01 Nov 2010